Personalis, Inc. (PSNL)
8.30
+0.01
(+0.12%)
USD |
NASDAQ |
Feb 25, 16:00
8.30
0.00 (0.00%)
After-Hours: 20:00
Personalis Research and Development Expense (Quarterly) : 12.17M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 92.33M |
| Hologic, Inc. | 60.50M |
| Pacific Biosciences of California, Inc. | 22.88M |
| Twist Bioscience Corp. | 17.13M |
| Ionis Pharmaceuticals, Inc. | 217.13M |